Your email has been successfully added to our mailing list.

×
0.00117004680187212 0.00136505460218409 -0.000390015600623947 -0.00136505460218409 0.000877535101404089 0.000195007800311974 0.000780031201248033 -0.00207488299531983
Stock impact report

Bristol-Myers Squibb stock drops 6% after FDA delays approval deadline for cancer drug [MarketWatch]

Bristol-Myers Squibb Company (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
Company Research Source: MarketWatch
Bristol-Myers Squibb stock drops 6% after FDA delays approval deadline for cancer drug Bristol-Myers Squibb Co. BMY, -5.64% shares dropped nearly 6% in extremely heavy Monday morning trade after the company said that, because of new information from a cancer clinical trial, the U.S. Food and Drug Administration is extending the review period for the company's new drug application by three months. This "major amendment to filing overshadows data presentations at [European Society for Medical Oncology]," a recent and major cancer conference, SunTrust Robinson Humphrey analyst John Boris, who rates the company "buy" with a $67 price target, said. The FDA now aims for an approval decision on the drug by or on May 20, 2019. The trial, called CheckMate-227, is an ongoing phase 3 study testing Bristol-Myers' drug Opdivo plus a low dose of another Bristol-Myers drug, Yervoy, against chemotherapy in metastatic first-line non-small cell lung cancer. The new information that Bristol-Myers sub Show less Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for BMY alerts
Opt-in for
BMY alerts

from News Quantified
Opt-in for
BMY alerts

from News Quantified